Lotta Vrang

Design of a SARS-CoV-2 papain-like protease inhibitor with antiviral efficacy in a mouse model

Covalent targeted radioligands potentiate radionuclide therapy

Induced‐Fit Binding of the Macrocyclic Noncovalent Inhibitor TMC435 to its HCV NS3/NS4A Protease Target

Urea−PETT Compounds as a New Class of HIV-1 Reverse Transcriptase Inhibitors. 3. Synthesis and Further Structure−Activity Relationship Studies of PETT Analogues